In News

MédiS, a generic pharmaceuticals business with operations in Tunisia and Algeria, has agreed to acquire Winthrop Pharma Senegal from Sanofi in an undisclosed deal. Actis acquired what was described as “a meaningful stake” in MédiS from fellow-private equity investor AfricInvest in late August last year.

Read more…